LOS ANGELES, March 29 (UPI) -- Doctors at the Children's Hospital of Los Angeles announced the start of a trial for immunotherapy treatment in children with acute lymphoblastic leukemia, or ALL, one of the most common cancers found in children.
The treatment, called KTE-C19, will be tested on 75 children between ages 2 and 21 with treatment-resistant forms of ALL following significant success in a previous, smaller trial.